Dendritic cell recovery post-lymphodepletion: A potential mechanism for anti-cancer adoptive T cell therapy and vaccination

Cancer Immunology, Immunotherapy

Volumn 59, Issue 3, 2010, Pages 341-353

  Salem, Mohamed Labib ^a,b   Cole, David J ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Adoptive T cell transfer; Cancer; Chemotherapy; Dendritic cells; Lymphodepletion; Tumor; Vaccination

Indexed keywords

TUMOR ANTIGEN;

ADJUVANT CHEMOTHERAPY; ADOPTIVE TRANSFER; ANTIGEN PRESENTING CELL; ANTINEOPLASTIC ACTIVITY; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CELL ACTIVATION; CELL EXPANSION; CELL SURVIVAL; CELL TRANSFER; DENDRITIC CELL; EX VIVO STUDY; LYMPHOCYTE DEPLETION; LYMPHOCYTOPENIA; PRIORITY JOURNAL; PROPHYLAXIS; RECIPIENT; REVIEW; T LYMPHOCYTE; VACCINATION;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, NEOPLASM; CANCER VACCINES; DENDRITIC CELLS; HUMANS; LYMPHOCYTE DEPLETION; NEOPLASMS; T-LYMPHOCYTES; VACCINATION;

EID: 73349118752     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-009-0792-6     Document Type: Review

References (141)

1. JD Abad C Wrzensinski W Overwijk MA De Witte A Jorritsma C Hsu L Gattinoni CJ Cohen CM Paulos DC Palmer JB Haanen TN Schumacher SA Rosenberg NP Restifo RA Morgan 2008 T-cell receptor gene therapy of established tumors in a murine melanoma model J Immunother 31 1 6 1:CAS:528:DC%2BD2sXhsVGgtL%2FF 18157006
2. B Almand JI Clark E Nikitina J van Beynen NR English SC Knight DP Carbone DI Gabrilovich 2001 Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer J Immunol 166 678 689 1:CAS:528:DC%2BD3MXis1elsw%3D%3D 11123353
3. I Angulo FG de las Heras JF Garcia-Bustos D Gargallo MA Munoz-Fernandez M Fresno 2000 Nitric oxide-producing CD11b(+)Ly-6G(Gr-1)(+)CD31(ER-MP12)(+) cells in the spleen of cyclophosphamide-treated mice: implications for T-cell responses in immunosuppressed mice Blood 95 212 220 1:CAS:528: DC%2BD3cXhslKhtQ%3D%3D 10607705
4. I Angulo MB Jimenez-Diaz JF Garcia-Bustos D Gargallo FG de las Heras MA Munoz-Fernandez M Fresno 2002 Candida albicans infection enhances immunosuppression induced by cyclophosphamide by selective priming of suppressive myeloid progenitors for NO production Cell Immunol 218 46 58 1:CAS:528:DC%2BD38XpsF2ksbk%3D 12470613
5. PA Antony CM Paulos M Ahmadzadeh A Akpinarli DC Palmer N Sato A Kaiser CS Hinrichs CA Klebanoff Y Tagaya NP Restifo 2006 Interleukin-2-dependent mechanisms of tolerance and immunity in vivo J Immunol 176 5255 5266 1:CAS:528:DC%2BD28XjsFagtLs%3D 16621991
6. PA Antony CA Piccirillo A Akpinarli SE Finkelstein PJ Speiss DR Surman DC Palmer CC Chan CA Klebanoff WW Overwijk SA Rosenberg NP Restifo 2005 CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells J Immunol 174 2591 2601 1:CAS:528:DC%2BD2MXhsFeru7Y%3D 15728465
7. L Apetoh F Ghiringhelli A Tesniere M Obeid C Ortiz A Criollo G Mignot MC Maiuri E Ullrich P Saulnier H Yang S Amigorena B Ryffel FJ Barrat P Saftig F Levi R Lidereau C Nogues JP Mira A Chompret V Joulin F Clavel-Chapelon J Bourhis F Andre S Delaloge T Tursz G Kroemer L Zitvogel 2007 Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy Nat Med 13 1050 1059 1:CAS:528:DC%2BD2sXhtVSgtr3E 17704786
8. V Apostolopoulos V Popovski IF McKenzie 1998 Cyclophosphamide enhances the CTL precursor frequency in mice immunized with MUC1-mannan fusion protein (M-FP) J Immunother 21 109 113 1:CAS:528:DyaK1cXisFGqs74%3D 9551361
9. M Awwad RJ North 1988 Cyclophosphamide (Cy)-facilitated adoptive immunotherapy of a Cy- resistant tumour. Evidence that Cy permits the expression of adoptive T- cell mediated immunity by removing suppressor T cells rather than by reducing tumour burden Immunology 65 87 92 1:CAS:528:DyaL1cXlvVeitL4%3D 2972604
10. F Belardelli M Ferrantini 2002 Cytokines as a link between innate and adaptive antitumor immunity Trends Immunol 23 201 208 1:CAS:528: DC%2BD38XitlGhs7k%3D 11923115
11. M Bellone 2000 Apoptosis, cross-presentation, and the fate of the antigen specific immune response Apoptosis 5 307 314 1:CAS:528:DC%2BD3cXos1Ortr4%3D 11227210
12. H Ben-Hur G Kossoy N Kossoy I Zusman 2002 Response of the immune system of mammary tumor-bearing rats to cyclophosphamide and soluble low-molecular-mass tumor-associated antigens: the bone marrow and thymus Int J Mol Med 10 517 521 1:CAS:528:DC%2BD38XotVCqsb0%3D 12239604
13. H Ben-Hur G Kossoy Y Tendler N Kossoy I Zusman 2002 Effects of cyclophosphamide and soluble tumor-associated antigens on lymphoid infiltration, proliferative activity and rate of apoptosis in chemically-induced rat mammary tumors In Vivo 16 287 292 1:CAS:528:DC%2BD3sXnsVWg 12494865
14. H Ben-Hur G Kossoy J Zandbank I Zusman 2002 Response of the immune system of mammary tumor-bearing rats to cyclophosphamide and soluble low-molecular-mass tumor-associated antigens: rate of lymphoid infiltration and distribution of T lymphocytes in tumors Int J Mol Med 9 425 430 1:CAS:528:DC%2BD38XivFejsb0%3D 11891540
15. JR Berenson AB Einstein Jr A Fefer 1975 Syngeneic adoptive immunotherapy and chemoimmunotherapy of a Friend leukemia: requirement for T cells J Immunol 115 234 238 1:STN:280:DyaE2M3ht1aisw%3D%3D 1080165
16. P Berraondo C Nouze X Preville D Ladant C Leclerc 2007 Eradication of large tumors in mice by a tritherapy targeting the innate, adaptive, and regulatory components of the immune system Cancer Res 67 8847 8855 1:CAS:528:DC%2BD2sXhtVCit7jL 17875726
17. L Bracci F Moschella P Sestili V La Sorsa M Valentini I Canini S Baccarini S Maccari C Ramoni F Belardelli E Proietti 2007 Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, B-cell and T-cell homeostatic proliferation, and specific tumor infiltration Clin Cancer Res 13 644 653 1:CAS:528:DC%2BD2sXoslSrsQ%3D%3D 17255288
18. S Brode A Cooke 2008 Immune-potentiating effects of the chemotherapeutic drug cyclophosphamide Crit Rev Immunol 28 109 126 1:CAS:528:DC%2BD1cXmtFKhs7c%3D 18540827
19. FR Carbone GT Belz WR Heath 2004 Transfer of antigen between migrating and lymph node-resident DCs in peripheral T-cell tolerance and immunity Trends Immunol 25 655 658 1:CAS:528:DC%2BD2cXptl2ktLg%3D 15530835
20. WA Cavanagh BA Tjoa H Ragde 2007 Chemotherapy followed by syngeneic dendritic cell injection in the mouse: findings and implications for human treatment Urology 70 36 41 18194710
21. S Cohen J Haimovich N Hollander 2009 Dendritic cell-based therapeutic vaccination against myeloma: vaccine formulation determines efficacy against light chain myeloma J Immunol 182 1667 1673 1:CAS:528:DC%2BD1MXnsVCjtw%3D%3D 19155516
22. CA Corzo MJ Cotter P Cheng F Cheng S Kusmartsev E Sotomayor T Padhya TV McCaffrey JC McCaffrey DI Gabrilovich 2009 Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells J Immunol 182 5693 5701 1:CAS:528:DC%2BD1MXkslKhs7g%3D 19380816
23. JM Curtsinger DC Lins MF Mescher 1998 CD8+ memory T cells (CD44high, Ly-6C+) are more sensitive than naive cells to (CD44low, Ly-6C-) to TCR/CD8 signaling in response to antigen J Immunol 160 3236 3243 1:CAS:528: DyaK1cXitFWnu7g%3D 9531279
24. CM Diaz-Montero S El Naggar A Al Khami R El Naggar AJ Montero DJ Cole ML Salem 2008 Priming of naive CD8+ T cells in the presence of IL-12 selectively enhances the survival of CD8+CD62Lhi cells and results in superior anti-tumor activity in a tolerogenic murine model Cancer Immunol Immunother 57 563 572 1:CAS:528:DC%2BD1cXhtV2isrs%3D 17726606
25. CM Diaz-Montero ML Salem MI Nishimura E Garrett-Mayer DJ Cole AJ Montero 2009 Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy Cancer Immunol Immunother 58 49 59 1:CAS:528:DC%2BD1cXht1yqs7bN 18446337
26. TJ Eberlein M Rosenstein SA Rosenberg 1982 Regression of a disseminated syngeneic solid tumor by systemic transfer of lymphoid cells expanded in interleukin 2 J Exp Med 156 385 397 1:STN:280:DyaL383ktVyruw%3D%3D 6980254
27. AA Eggert MW Schreurs OC Boerman WJ Oyen AJ de Boer CJ Punt CG Figdor GJ Adema 1999 Biodistribution and vaccine efficiency of murine dendritic cells are dependent on the route of administration Cancer Res 59 3340 3345 1:CAS:528:DyaK1MXks1OmsrY%3D 10416590
28. M Eyrich G Burger K Marquardt W Budach K Schilbach D Niethammer PG Schlegel 2005 Sequential expression of adhesion and costimulatory molecules in graft-versus-host disease target organs after murine bone marrow transplantation across minor histocompatibility antigen barriers Biol Blood Marrow Transplant 11 371 382 1:CAS:528:DC%2BD2MXltlClsbo%3D 15846291
29. L Fong Y Hou A Rivas C Benike A Yuen GA Fisher MM Davis EG Engleman 2001 Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy Proc Natl Acad Sci USA 98 8809 8814 1:CAS:528: DC%2BD3MXls1Wiur4%3D 11427731
30. DI Gabrilovich S Nagaraj 2009 Myeloid-derived suppressor cells as regulators of the immune system Nat Rev Immunol 9 162 174 1:CAS:528: DC%2BD1MXhsFeqsbw%3D 19197294
31. S Gallucci M Lolkema P Matzinger 1999 Natural adjuvants: endogenous activators of dendritic cells Nat Med 5 1249 1255 1:CAS:528:DyaK1MXnt1ynsbk%3D 10545990
32. T Garrity R Pandit MA Wright J Benefield S Keni MR Young 1997 Increased presence of CD34+ cells in the peripheral blood of head and neck cancer patients and their differentiation into dendritic cells Int J Cancer 73 663 669 1:STN:280:DyaK1c%2FlvVKrtw%3D%3D 9398043
33. L Gattinoni SE Finkelstein CA Klebanoff PA Antony DC Palmer PJ Spiess LN Hwang Z Yu C Wrzesinski DM Heimann CD Surh SA Rosenberg NP Restifo 2005 Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells J Exp Med 202 907 912 1:CAS:528:DC%2BD2MXhtVygt73L 16203864
34. L Gattinoni DJ Powell Jr SA Rosenberg NP Restifo 2006 Adoptive immunotherapy for cancer: building on success Nat Rev Immunol 6 383 393 1:CAS:528:DC%2BD28XjslOgsrw%3D 16622476
35. Y Gazitt C Akay C Thomas 3rd 2006 No polarization of type 1 or type 2 precursor dendritic cells in peripheral blood stem cell collections of non-hodgkin's lymphoma patients mobilized with cyclophosphamide plus G-CSF, GM-CSF, or GM-CSF followed by G-CSF Stem Cells Dev 15 269 277 1:CAS:528:DC%2BD28XjvFyqu78%3D 16646673
36. A Gruber T Brocker 2005 MHC class I-positive dendritic cells (DC) control CD8 T cell homeostasis in vivo: T cell lymphopenia as a prerequisite for DC-mediated homeostatic proliferation of naive CD8 T cells J Immunol 175 201 206 1:CAS:528:DC%2BD2MXltlyntb8%3D 15972649
37. F Guo CK Chang HH Fan XX Nie YN Ren YY Liu LH Zhao 2008 Anti-tumour effects of exosomes in combination with cyclophosphamide and polyinosinic-polycytidylic acid J Int Med Res 36 1342 1353 1:CAS:528: DC%2BD1MXhsValtrc%3D 19094445
38. DE Hallahan DR Spriggs MA Beckett DW Kufe RR Weichselbaum 1989 Increased tumor necrosis factor alpha mRNA after cellular exposure to ionizing radiation Proc Natl Acad Sci USA 86 10104 10107 1:CAS:528:DyaK3cXpsVKrtg%3D%3D 2602359
39. DE Hallahan MJ Staba-Hogan S Virudachalam A Kolchinsky 1998 X-ray-induced P-selectin localization to the lumen of tumor blood vessels Cancer Res 58 5216 5220 1:CAS:528:DyaK1cXnsFSmtb0%3D 9823335
40. DE Hallahan S Virudachalam 1999 Accumulation of P-selectin in the lumen of irradiated blood vessels Radiat Res 152 6 13 1:CAS:528:DyaK1MXktlClurs%3D 10381836
41. H He P Wisner G Yang HM Hu D Haley W Miller A O'Hara WG Alvord CH Clegg BA Fox WJ Urba EB Walker 2006 Combined IL-21 and Low-Dose IL-2 therapy induces anti-tumor immunity and long-term curative effects in a murine melanoma tumor model J Transl Med 4 24 1:CAS:528:DC%2BD2sXlvFyntrw%3D 16772043
42. CS Hinrichs R Spolski CM Paulos L Gattinoni KW Kerstann DC Palmer CA Klebanoff SA Rosenberg WJ Leonard NP Restifo 2008 IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy Blood 111 5326 5333 1:CAS:528:DC%2BD1cXntFWnsrk%3D 18276844
43. D Hirschhorn-Cymerman GA Rizzuto T Merghoub AD Cohen F Avogadri AM Lesokhin AD Weinberg JD Wolchok AN Houghton 2009 OX40 engagement and chemotherapy combination provides potent antitumor immunity with concomitant regulatory T cell apoptosis J Exp Med 206 1103 1116 1:CAS:528: DC%2BD1MXlvVGmurY%3D 19414558
44. L Holtl R Ramoner C Zelle-Rieser H Gander T Putz C Papesh W Nussbaumer C Falkensammer G Bartsch M Thurnher 2005 Allogeneic dendritic cell vaccination against metastatic renal cell carcinoma with or without cyclophosphamide Cancer Immunol Immunother 54 663 670 15918076
45. JH Hong CS Chiang CY Tsao PY Lin WH McBride CJ Wu 1999 Rapid induction of cytokine gene expression in the lung after single and fractionated doses of radiation Int J Radiat Biol 75 1421 1427 1:CAS:528:DyaK1MXns12mtrY%3D 10597915
46. SK Hoover SK Barrett TM Turk TC Lee HD Bear 1990 Cyclophosphamide and abrogation of tumor-induced suppressor T cell activity Cancer Immunol Immunother 31 121 127 1:CAS:528:DyaK3cXkvFWjs78%3D 2138931
47. R Horvath V Budinsky J Kayserova T Kalina R Formankova J Stary J Bartunkova P Sedlacek R Spisek 2009 Kinetics of dendritic cells reconstitution and costimulatory molecules expression after myeloablative allogeneic haematopoetic stem cell transplantation: implications for the development of acute graft-versus host disease Clin Immunol 131 60 69 1:CAS:528: DC%2BD1MXktFWkurk%3D 19081305
48. DE Hu AM Moore LL Thomsen KM Brindle 2004 Uric acid promotes tumor immune rejection Cancer Res 64 5059 5062 1:CAS:528:DC%2BD2cXmtF2mt74%3D 15289304
49. J Huang Y Wang J Guo H Lu X Lin L Ma S Teitz-Tennenbaum AE Chang Q Li 2007 Radiation-induced apoptosis along with local and systemic cytokine elaboration is associated with DC plus radiotherapy-mediated renal cell tumor regression Clin Immunol 123 298 310 1:CAS:528:DC%2BD2sXmtVGgur8%3D 17449328
50. SP Huck SC Tang KA Andrew J Yang JL Harper F Ronchese 2008 Activation and route of administration both determine the ability of bone marrow-derived dendritic cells to accumulate in secondary lymphoid organs and prime CD8+ T cells against tumors Cancer Immunol Immunother 57 63 71 17609951
51. LN Hwang Z Yu DC Palmer NP Restifo 2006 The in vivo expansion rate of properly stimulated transferred CD8+ T cells exceeds that of an aggressively growing mouse tumor Cancer Res 66 1132 1138 1:CAS:528:DC%2BD28XlsFOguw%3D%3D 16424050
52. S Ibe Z Qin T Schuler S Preiss T Blankenstein 2001 Tumor rejection by disturbing tumor stroma cell interactions J Exp Med 194 1549 1559 1:CAS:528:DC%2BD3MXovVOkt7w%3D 11733570
53. Ikezawa Y, Nakazawa M, Tamura C, Takahashi K, Minami M, Ikezawa Z (2005) Cyclophosphamide decreases the number, percentage and the function of CD25(+) CD4(+) regulatory T cells, which suppress induction of contact hypersensitivity. J Dermatol Sci
54. H Ishihara I Tanaka K Nemoto K Tsuneoka C Cheeramakara K Yoshida H Ohtsu 1995 Immediate-early, transient induction of the interleukin-1 beta gene in mouse spleen macrophages by ionizing radiation J Radiat Res (Tokyo) 36 112 124 1:CAS:528:DyaK2MXnvFShsLg%3D
55. A Jabbari JT Harty 2005 Cutting edge: differential self-peptide/MHC requirement for maintaining CD8 T cell function versus homeostatic proliferation J Immunol 175 4829 4833 1:CAS:528:DC%2BD2MXhtVylsb3F 16210583
56. B Jahrsdorfer GJ Weiner 2008 CpG oligodeoxynucleotides as immunotherapy in cancer Update Cancer Ther 3 27 32 19255607
57. H Kawashima 2006 Roles of sulfated glycans in lymphocyte homing Biol Pharm Bull 29 2343 2349 1:CAS:528:DC%2BD2sXpsVKquw%3D%3D 17142960
58. RM Kedl WA Rees DA Hildeman B Schaefer T Mitchell J Kappler P Marrack 2000 T cells compete for access to antigen-bearing antigen-presenting cells J Exp Med 192 1105 1113 1:CAS:528:DC%2BD3cXnsVaru7c%3D 11034600
59. O Kepp A Tesniere F Schlemmer M Michaud L Senovilla L Zitvogel G Kroemer 2009 Immunogenic cell death modalities and their impact on cancer treatment Apoptosis 14 364 375 19145485
60. CA Klebanoff SE Finkelstein DR Surman MK Lichtman L Gattinoni MR Theoret N Grewal PJ Spiess PA Antony DC Palmer Y Tagaya SA Rosenberg TA Waldmann NP Restifo 2004 IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells Proc Natl Acad Sci USA 101 1969 1974 1:CAS:528:DC%2BD2cXhs1Skurs%3D 14762166
61. CA Klebanoff L Gattinoni P Torabi-Parizi K Kerstann AR Cardones SE Finkelstein DC Palmer PA Antony ST Hwang SA Rosenberg TA Waldmann NP Restifo 2005 Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells Proc Natl Acad Sci USA 102 9571 9576 1:CAS:528:DC%2BD2MXmsVakt7o%3D 15980149
62. CA Klebanoff L Gattioni NP Restifo 2006 CD8+ T-cell memory in tumot immunology and immunotherapy Immunol Rev 211 214 224 1:CAS:528: DC%2BD28Xot1Grsbw%3D 16824130
63. CA Klebanoff HT Khong PA Antony DC Palmer NP Restifo 2005 Sinks, suppressors and antigen presenters: how lymphodepletion enhances T cell-mediated tumor immunotherapy Trends Immunol 26 111 117 1:CAS:528:DC%2BD2MXms1Cktw%3D%3D 15668127
64. HJ Ko JM Lee YJ Kim YS Kim KA Lee CY Kang 2009 Immunosuppressive myeloid-derived suppressor cells can be converted into immunogenic APCs with the help of activated NKT cells: an alternative cell-based antitumor vaccine J Immunol 182 1818 1828 1:CAS:528:DC%2BD1MXhsFKktL0%3D 19201833
65. JS Ko RM Bukowski JH Fincke 2009 Myeloid-derived suppressor cells: a novel therapeutic target Curr Oncol Rep 11 87 93 1:CAS:528:DC%2BD1MXltVSlur0%3D 19216839
66. J Kohlmeyer M Cron J Landsberg T Bald M Renn S Mikus S Bondong D Wikasari E Gaffal G Hartmann T Tuting 2009 Complete regression of advanced primary and metastatic mouse melanomas following combination chemoimmunotherapy Cancer Res 69 6265 6274 1:CAS:528:DC%2BD1MXpt1Cgurw%3D 19622767
67. N Koike S Pilon-Thomas JJ Mule 2008 Nonmyeloablative chemotherapy followed by T-cell adoptive transfer and dendritic cell-based vaccination results in rejection of established melanoma J Immunother 31 402 412 18391755
68. MB Lappin JM Weiss V Delattre B Mai H Dittmar C Maier K Manke S Grabbe S Martin JC Simon 1999 Analysis of mouse dendritic cell migration in vivo upon subcutaneous and intravenous injection Immunology 98 181 188 1:CAS:528:DyaK1MXmslKiu7g%3D 10540216
69. J Lau M Sartor KF Bradstock S Vuckovic DJ Munster DN Hart 2007 Activated circulating dendritic cells after hematopoietic stem cell transplantation predict acute graft-versus-host disease Transplantation 83 839 846 17460553
70. J Limpens M Van Meijer HM Van Santen WT Germeraad K Hoeben-Schornagel M Breel RJ Scheper G Kraal 1991 Alterations in dendritic cell phenotype and function associated with immunoenhancing effects of a subcutaneously administered cyclophosphamide derivative Immunology 73 255 263 1:CAS:528:DyaK3MXlsV2qtLY%3D 1879874
71. F Liu J Poursine-Laurent DC Link 1997 The granulocyte colony-stimulating factor receptor is required for the mobilization of murine hematopoietic progenitors into peripheral blood by cyclophosphamide or interleukin-8 but not flt-3 ligand Blood 90 2522 2528 1:CAS:528:DyaK2sXmtlegtr0%3D 9326216
72. JY Liu Y Wu XS Zhang JL Yang HL Li YQ Mao Y Wang X Cheng YQ Li JC Xia M Masucci YX Zeng 2007 Single administration of low dose cyclophosphamide augments the antitumor effect of dendritic cell vaccine Cancer Immunol Immunother 56 1597 1604 1:CAS:528:DC%2BD2sXotVKktr0%3D 17440723
73. MT Lotze SA Rosenberg 1986 Results of clinical trials with the administration of interleukin 2 and adoptive immunotherapy with activated cells in patients with cancer Immunobiology 172 420 437 1:STN:280:DyaL2s7gslKruw%3D%3D 3100435
74. Y Lou G Wang G Lizee GJ Kim SE Finkelstein C Feng NP Restifo P Hwu 2004 Dendritic cells strongly boost the antitumor activity of adoptively transferred T cells in vivo Cancer Res 64 6783 6790 1:CAS:528:DC%2BD2cXnsFOksLg%3D 15374997
75. J Ma WJ Urba L Si Y Wang BA Fox HM Hu 2003 Anti-tumor T cell response and protective immunity in mice that received sublethal irradiation and immune reconstitution Eur J Immunol 33 2123 2132 1:CAS:528:DC%2BD3sXmsFWqtbY%3D 12884286
76. I Marigo L Dolcetti P Serafini P Zanovello V Bronte 2008 Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells Immunol Rev 222 162 179 1:CAS:528:DC%2BD1cXlsFejt74%3D 18364001
77. FM Marincola S Ettinghausen PA Cohen LB Cheshire NP Restifo JJ Mule SA Rosenberg 1994 Treatment of established lung metastases with tumor-infiltrating lymphocytes derived from a poorly immunogenic tumor engineered to secrete human TNF-alpha J Immunol 152 3500 3513 1:STN:280:DyaK2c7psVWisg%3D%3D 8144931
78. A MartIn-Fontecha S Sebastiani UE Hopken M Uguccioni M Lipp A Lanzavecchia F Sallusto 2003 Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming J Exp Med 198 615 621 1:CAS:528:DC%2BD3sXms1WisLo%3D 12925677
79. WH McBride CS Chiang JL Olson CC Wang JH Hong F Pajonk GJ Dougherty KS Iwamoto M Pervan YP Liao 2004 A sense of danger from radiation Radiat Res 162 1 19 1:CAS:528:DC%2BD2cXlslWhtL4%3D 15222781
80. MA Mihalyo AD Doody JP McAleer EC Nowak M Long Y Yang AJ Adler 2004 In vivo cyclophosphamide and IL-2 treatment impedes self-antigen-induced effector CD4 cell tolerization: implications for adoptive immunotherapy J Immunol 172 5338 5345 1:CAS:528:DC%2BD2cXjt1CksbY%3D 15100273
81. MB Mokyr AT Place JE Artwohl VE Valli 2006 Importance of signaling via the IFN-alpha/beta receptor on host cells for the realization of the therapeutic benefits of cyclophosphamide for mice bearing a large MOPC-315 tumor Cancer Immunol Immunother 55 459 468 1:CAS:528:DC%2BD28XjtVyjtA%3D%3D 15965646
82. SJ Morrison DE Wright IL Weissman 1997 Cyclophosphamide/granulocyte colony-stimulating factor induces hematopoietic stem cells to proliferate prior to mobilization Proc Natl Acad Sci USA 94 1908 1913 1:CAS:528:DyaK2sXhslegs7o%3D 9050878
83. P Muranski A Boni C Wrzesinski DE Citrin SA Rosenberg R Childs NP Restifo 2006 Increased intensity lymphodepletion and adoptive immunotherapy-how far can we go? Nat Clin Pract Oncol 3 668 681 1:CAS:528:DC%2BD2sXksFKkug%3D%3D 17139318
84. S Nagaraj M Collazo CA Corzo JI Youn M Ortiz D Quiceno DI Gabrilovich 2009 Regulatory myeloid suppressor cells in health and disease Cancer Res 69 7503 7506 1:CAS:528:DC%2BD1MXht1Skt7rM 19752086
85. M Nakayama K Itoh E Takahashi 1997 Cyclophosphamide-induced bacterial translocation in Escherichia coli C25-monoassociated specific pathogen-free mice Microbiol Immunol 41 587 593 1:CAS:528:DyaK2sXmt1Oqu7Y%3D 9310937
86. MP Ndejembi AL Tang DL Farber 2007 Reshaping the past: Strategies for modulating T-cell memory immune responses Clin Immunol 122 1 12 1:CAS:528:DC%2BD28Xhtlalt7nF 16916619
87. S Neben K Marcus P Mauch 1993 Mobilization of hematopoietic stem and progenitor cell subpopulations from the marrow to the blood of mice following cyclophosphamide and/or granulocyte colony-stimulating factor Blood 81 1960 1967 1:CAS:528:DyaK3sXisVOisrY%3D 7681707
88. K Nemoto H Ishihara I Tanaka G Suzuki K Tsuneoka K Yoshida H Ohtsu 1995 Expression of IL-1 beta mRNA in mice after whole body X-irradiation J Radiat Res (Tokyo) 36 125 133 1:CAS:528:DyaK2MXnvFShsLk%3D
89. N Okada M Tsujino Y Hagiwara A Tada Y Tamura K Mori T Saito S Nakagawa T Mayumi T Fujita A Yamamoto 2001 Administration route-dependent vaccine efficiency of murine dendritic cells pulsed with antigens Br J Cancer 84 1564 1570 1:CAS:528:DC%2BD3MXltFaqsrg%3D 11384109
90. WW Overwijk KE de Visser FH Tirion LA de Jong TW Pols YU van der Velden JG van den Boorn AM Keller WA Buurman MR Theoret B Blom NP Restifo AM Kruisbeek RA Kastelein JB Haanen 2006 Immunological and antitumor effects of IL-23 as a cancer vaccine adjuvant J Immunol 176 5213 5222 1:CAS:528:DC%2BD28XjsFagt7o%3D 16621986
91. WW Overwijk MR Theoret SE Finkelstein DR Surman LA de Jong FA Vyth-Dreese TA Dellemijn PA Antony PJ Spiess DC Palmer DM Heimann CA Klebanoff Z Yu LN Hwang L Feigenbaum AM Kruisbeek SA Rosenberg NP Restifo 2003 Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells J Exp Med 198 569 580 1:CAS:528:DC%2BD3sXms1WisL4%3D 12925674
92. WW Overwijk A Tsung KR Irvine MR Parkhurst TJ Goletz K Tsung MW Carroll C Liu B Moss SA Rosenberg NP Restifo 1998 gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligand J Exp Med 188 277 286 1:CAS:528:DyaK1cXkvVaqt7s%3D 9670040
93. AS Pak MA Wright JP Matthews SL Collins GJ Petruzzelli MR Young 1995 Mechanisms of immune suppression in patients with head and neck cancer: presence of CD34(+) cells which suppress immune functions within cancers that secrete granulocyte-macrophage colony-stimulating factor Clin Cancer Res 1 95 103 1:CAS:528:DyaK2MXlvVarsrs%3D 9815891
94. R Pandit DM Lathers NM Beal T Garrity MR Young 2000 CD34+ immune suppressive cells in the peripheral blood of patients with head and neck cancer Ann Otol Rhinol Laryngol 109 749 754 1:STN:280:DC%2BD3cvisVShtA%3D%3D 10961808
95. CM Paulos A Kaiser C Wrzesinski CS Hinrichs L Cassard A Boni P Muranski L Sanchez-Perez DC Palmer Z Yu PA Antony L Gattinoni SA Rosenberg NP Restifo 2007 Toll-like receptors in tumor immunotherapy Clin Cancer Res 13 5280 5289 1:CAS:528:DC%2BD2sXhtVCitL7E 17875756
96. CM Paulos C Wrzesinski A Kaiser CS Hinrichs M Chieppa L Cassard DC Palmer A Boni P Muranski Z Yu L Gattinoni PA Antony SA Rosenberg NP Restifo 2007 Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling J Clin Invest 117 2197 2204 1:CAS:528:DC%2BD2sXoslOns78%3D 17657310
97. B Pelaez JA Campillo JA Lopez-Asenjo JL Subiza 2001 Cyclophosphamide induces the development of early myeloid cells suppressing tumor cell growth by a nitric oxide-dependent mechanism J Immunol 166 6608 6615 1:CAS:528: DC%2BD3MXjvFartbo%3D 11359814
98. RP Phipps TE Mandel CT Schnizlein JG Tew 1984 Anamnestic responses induced by antigen persisting on follicular dendritic cells from cyclophosphamide-treated mice Immunology 51 387 397 1:CAS:528:DyaL2cXhtlahurw%3D 6607214
99. RM Prins CJ Shu CG Radu DD Vo H Khan-Farooqi H Soto MY Yang MS Lin S Shelly ON Witte A Ribas LM Liau 2008 Anti-tumor activity and trafficking of self, tumor-specific T cells against tumors located in the brain Cancer Immunol Immunother 57 1279 1289 1:CAS:528:DC%2BD1cXnsFeis7g%3D 18253732
100. HC Probst M van den Broek 2005 Priming of CTLs by lymphocytic choriomeningitis virus depends on dendritic cells J Immunol 174 3920 3924 1:CAS:528:DC%2BD2MXisVChsrw%3D 15778347
101. E Proietti G Greco B Garrone S Baccarini C Mauri M Venditti D Carlei F Belardelli 1998 Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice J Clin Invest 101 429 441 1:CAS:528:DyaK1cXmtF2hsA%3D%3D 9435316
102. B Pulendran R Ahmed 2006 Translating innate immunity into immunological memory: implications for vaccine development Cell 124 849 863 1:CAS:528:DC%2BD28Xit1Kltbg%3D 16497593
103. FJ Radcliff DA Caruso C Koina MJ Riordan AW Roberts ML Tang CM Baum SL Woulfe DM Ashley 2002 Mobilization of dendritic cells in cancer patients treated with granulocyte colony-stimulating factor and chemotherapy Br J Haematol 119 204 211 1:CAS:528:DC%2BD38XovFGqur0%3D 12358927
104. V Radojcic KB Bezak M Skarica MA Pletneva K Yoshimura RD Schulick L Luznik 2009 Cyclophosphamide resets dendritic cell homeostasis and enhances antitumor immunity through effects that extend beyond regulatory T cell elimination Cancer Immunol Immunother 59 1 137 148 19590872
105. R Ramakrishnan S Antonia DI Gabrilovich 2008 Combined modality immunotherapy and chemotherapy: a new perspective Cancer Immunol Immunother 57 1523 1529 1:CAS:528:DC%2BD1cXovFyisbc%3D 18488219
106. C Reis e Sousa 2006 Dendritic cells in a mature age Nat Rev Immunol 6 476 483 1:CAS:528:DC%2BD28XkvVyrtro%3D 16691244
107. SM Rigby T Rouse EH Field 2003 Total lymphoid irradiation nonmyeloablative preconditioning enriches for IL-4-producing CD4+-TNK cells and skews differentiation of immunocompetent donor CD4+ cells Blood 101 2024 2032 1:CAS:528:DC%2BD3sXhslCrtbk%3D 12406908
108. SD Rosen 2004 Ligands for l-selectin: homing, inflammation, and beyond Annu Rev Immunol 22 129 156 1:CAS:528:DC%2BD2cXktlOgs78%3D 15032576
109. SA Rosenberg 1984 Immunotherapy of cancer by systemic administration of lymphoid cells plus interleukin-2 J Biol Response Mod 3 501 511 1:CAS:528:DyaL2cXmt1ygs7g%3D 6389777
110. SA Rosenberg 2001 Progress in human tumour immunology and immunotherapy Nature 411 380 384 1:CAS:528:DC%2BD3MXktVSjs70%3D 11357146
111. SA Rosenberg BS Packard PM Aebersold D Solomon SL Topalian ST Toy P Simon MT Lotze JC Yang CA Seipp, et al. 1988 Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report N Engl J Med 319 1676 1680 1:STN:280:DyaL1M%2FntVKmsw%3D%3D 3264384
112. SA Rosenberg NP Restifo JC Yang RA Morgan ME Dudley 2008 Adoptive cell transfer: a clinical path to effective cancer immunotherapy Nat Rev Cancer 8 299 308 1:CAS:528:DC%2BD1cXjsFCmsLg%3D 18354418
113. RE Roses M Xu GK Koski BJ Czerniecki 2008 Radiation therapy and Toll-like receptor signaling: implications for the treatment of cancer Oncogene 27 200 207 1:CAS:528:DC%2BD1cXitl2hsA%3D%3D 18176601
114. Salem ML, AL-Khami AA, EL-Naggar SA, Díaz-Montero CM, Chen Y, Cole DJ (2009) Cyclophosphamide induces dynamic alterations in the host microenvironments resulting in a FLT3L-dependent expansion of dendritic cells. J Immunol (under revision)
115. ML Salem CM Diaz-Montero AA Al-Khami SA El-Naggar O Naga AJ Montero A Khafagy DJ Cole 2009 Recovery from cyclophosphamide-induced lymphopenia results in expansion of immature dendritic cells which can mediate enhanced prime-boost vaccination antitumor responses in vivo when stimulated with the TLR3 agonist poly(I:C) J Immunol 182 2030 2040 1:CAS:528:DC%2BD1MXhsFKkurg%3D 19201856
116. Salem ML, El-Naggar SA, Cole DJ (2009) Cyclophosphamide induces bone marrow to yield higher numbers of precursor dendritic cells in vitro capable of functional antigen presentation to T cells in vivo. Cell Immunol (submitted)
117. ML Salem SA El-Naggar A Kadima WE Gillanders DJ Cole 2006 The adjuvant effects of the toll-like receptor 3 ligand polyinosinic-cytidylic acid poly (I:C) on antigen-specific CD8+ T cell responses are partially dependent on NK cells with the induction of a beneficial cytokine milieu Vaccine 24 5119 5132 1:CAS:528:DC%2BD28Xltlemsrk%3D 16704888
118. ML Salem AN Kadima SA El-Naggar MP Rubinstein Y Chen WE Gillanders DJ Cole 2007 Defining the ability of cyclophosphamide preconditioning to enhance the antigen-specific CD8+ T-cell response to peptide vaccination: creation of a beneficial host microenvironment involving type I IFNs and myeloid cells J Immunother 30 40 53 1:CAS:528:DC%2BD2sXjtVCg 17198082
119. G Schiavoni F Mattei T Di Pucchio SM Santini L Bracci F Belardelli E Proietti 2000 Cyclophosphamide induces type I interferon and augments the number of CD44(hi) T lymphocytes in mice: implications for strategies of chemoimmunotherapy of cancer Blood 95 2024 2030 1:CAS:528:DC%2BD3cXhvVGgsL0%3D 10706870
120. TN Schumacher NP Restifo 2009 Adoptive T cell therapy of cancer Curr Opin Immunol 21 187 189 1:CAS:528:DC%2BD1MXlsVCgtLs%3D 19328668
121. M Shackleton ID Davis W Hopkins H Jackson N Dimopoulos T Tai Q Chen P Parente M Jefford KA Masterman D Caron W Chen E Maraskovsky J Cebon 2004 The impact of imiquimod, a Toll-like receptor-7 ligand (TLR7L), on the immunogenicity of melanoma peptide vaccination with adjuvant Flt3 ligand Cancer Immun 4 9 15384929
122. Y Shi JE Evans KL Rock 2003 Molecular identification of a danger signal that alerts the immune system to dying cells Nature 425 516 521 1:CAS:528:DC%2BD3sXnslSis7g%3D 14520412
123. Y Shi SA Galusha KL Rock 2006 Cutting edge: elimination of an endogenous adjuvant reduces the activation of CD8 T lymphocytes to transplanted cells and in an autoimmune diabetes model J Immunol 176 3905 3908 1:CAS:528: DC%2BD28Xis1ertLs%3D 16547223
124. W Song R Levy 2005 Therapeutic vaccination against murine lymphoma by intratumoral injection of naive dendritic cells Cancer Res 65 5958 5964 1:CAS:528:DC%2BD2MXlslOqt7k%3D 15994975
125. J Taieb N Chaput N Schartz S Roux S Novault C Menard F Ghiringhelli M Terme AF Carpentier G Darrasse-Jeze F Lemonnier L Zitvogel 2006 Chemoimmunotherapy of tumors: cyclophosphamide synergizes with exosome based vaccines J Immunol 176 2722 2729 1:CAS:528:DC%2BD28Xhs1ertrY%3D 16493027
126. A Tesniere T Panaretakis O Kepp L Apetoh F Ghiringhelli L Zitvogel G Kroemer 2008 Molecular characteristics of immunogenic cancer cell death Cell Death Differ 15 3 12 1:CAS:528:DC%2BD2sXhsVegurzO 18007663
127. Y Tong W Song RG Crystal 2001 Combined intratumoral injection of bone marrow-derived dendritic cells and systemic chemotherapy to treat pre-existing murine tumors Cancer Res 61 7530 7535 1:CAS:528:DC%2BD3MXnvFShsb0%3D 11606390
128. H Torihata F Ishikawa Y Okada Y Tanaka T Uchida T Suguro T Kakiuchi 2004 Irradiation up-regulates CD80 expression through two different mechanisms in spleen B cells, B lymphoma cells, and dendritic cells Immunology 112 219 227 1:CAS:528:DC%2BD2cXks12hs7k%3D 15147565
129. MP Vierboom GM Bos M Ooms R Offringa CJ Melief 2000 Cyclophosphamide enhances anti-tumor effect of wild-type p53-specific CTL Int J Cancer 87 253 260 1:CAS:528:DC%2BD3cXltV2rtr8%3D 10861484
130. S Vuckovic M Kim D Khalil CJ Turtle GV Crosbie N Williams L Brown K Williams C Kelly P Stravos R Rodwell GR Hill S Wright K Taylor D Gill P Marlton K Bradstock DN Hart 2003 Granulocyte-colony stimulating factor increases CD123hi blood dendritic cells with altered CD62L and CCR7 expression Blood 101 2314 2317 1:CAS:528:DC%2BD3sXit1egtrw%3D 12406901
131. S Wada K Yoshimura EL Hipkiss TJ Harris HR Yen MV Goldberg JF Grosso D Getnet AM Demarzo GJ Netto R Anders DM Pardoll CG Drake 2009 Cyclophosphamide augments antitumor immunity: studies in an autochthonous prostate cancer model Cancer Res 69 4309 4318 1:CAS:528:DC%2BD1MXlvFWltLc%3D 19435909
132. LX Wang R Li G Yang M Lim A O'Hara Y Chu BA Fox NP Restifo WJ Urba HM Hu 2005 Interleukin-7-dependent expansion and persistence of melanoma-specific T cells in lymphodepleted mice lead to tumor regression and editing Cancer Res 65 10569 10577 1:CAS:528:DC%2BD2MXht1Wgu7zK 16288050
133. DE Wright SH Cheshier AJ Wagers TD Randall JL Christensen IL Weissman 2001 Cyclophosphamide/granulocyte colony-stimulating factor causes selective mobilization of bone marrow hematopoietic stem cells into the blood after M phase of the cell cycle Blood 97 2278 2285 1:CAS:528:DC%2BD3MXivFOgt7k%3D 11290588
134. C Wrzesinski CM Paulos L Gattinoni DC Palmer A Kaiser Z Yu SA Rosenberg NP Restifo 2007 Hematopoietic stem cells promote the expansion and function of adoptively transferred antitumor CD8 T cells J Clin Invest 117 492 501 1:CAS:528:DC%2BD2sXhs1Oqt7w%3D 17273561
135. C Wrzesinski NP Restifo 2005 Less is more: lymphodepletion followed by hematopoietic stem cell transplant augments adoptive T-cell-based anti-tumor immunotherapy Curr Opin Immunol 17 195 201 1:CAS:528:DC%2BD2MXit1ChtLs%3D 15766681
136. CQ Xun JS Thompson CD Jennings SA Brown MB Widmer 1994 Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H-2-incompatible transplanted SCID mice Blood 83 2360 2367 1:CAS:528:DyaK2cXkslOgurg%3D 8161803
137. JI Youn S Nagaraj M Collazo DI Gabrilovich 2008 Subsets of myeloid-derived suppressor cells in tumor-bearing mice J Immunol 181 5791 5802 1:CAS:528:DC%2BD1cXhtF2hsL3I 18832739
138. T Zaft A Sapoznikov R Krauthgamer DR Littman S Jung 2005 CD11chigh dendritic cell ablation impairs lymphopenia-driven proliferation of naive and memory CD8+ T cells J Immunol 175 6428 6435 1:CAS:528:DC%2BD2MXhtF2jurrN 16272295
139. R Zeng R Spolski SE Finkelstein S Oh PE Kovanen CS Hinrichs CA Pise-Masison MF Radonovich JN Brady NP Restifo JA Berzofsky WJ Leonard 2005 Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function J Exp Med 201 139 148 1:CAS:528:DC%2BD2MXjvVekuw%3D%3D 15630141
140. B Zhang NA Bowerman JK Salama H Schmidt MT Spiotto A Schietinger P Yu YX Fu RR Weichselbaum DA Rowley DM Kranz H Schreiber 2007 Induced sensitization of tumor stroma leads to eradication of established cancer by T cells J Exp Med 204 49 55 1:CAS:528:DC%2BD2sXhtFGjsbY%3D 17210731
141. Y Zhang JP Louboutin J Zhu AJ Rivera SG Emerson 2002 Preterminal host dendritic cells in irradiated mice prime CD8+ T cell-mediated acute graft-versus-host disease J Clin Invest 109 1335 1344 1:CAS:528: DC%2BD38XjvFCls7o%3D 12021249